Partner: Cruz-Rangel Armando


Ostatnie publikacje
1.Sara Abigail R., Durán-Vargas A., Jesús Antonio R., Mendoza-Espinosa P., Cofas Vargas L.F., Armando C., Julio Isael P., García-Hernandez E., Targeting human prostaglandin reductase 1 with Licochalcone A: Insights from molecular dynamics and covalent docking studies, Biophysical Chemistry, ISSN: 0301-4622, DOI: 10.1016/j.bpc.2025.107410, Vol.320-321, pp.107410-1-15, 2025

Streszczenie:

Prostaglandin reductase 1 (PTGR1) is an NADPH-dependent enzyme critical to eicosanoid metabolism. Its elevated expression in malignant tumors often correlates with poor prognosis due to its role in protecting cells against reactive oxygen species. This study explores the inhibitory potential of licochalcone A, a flavonoid derived from Xinjiang licorice root, on human PTGR1. Using molecular dynamics simulations, we mapped the enzyme's conformational landscape, revealing a low-energy, rigid-body-like movement of the catalytic domain relative to the nucleotide-binding domain that governs PTGR1's transition between open and closed states. Simulations of NADPH-depleted dimer and NADPH-bound monomer highlighted the critical role of intersubunit interactions and coenzyme binding in defining PTGR1's conformational landscape, offering a deeper understanding of its functional adaptability as a holo-homodimer. Covalent docking, informed by prior chemoproteomic cross-linking data, revealed a highly favorable binding pose for licochalcone A at the NADPH-binding site. This pose aligned with a transient noncovalent binding pose inferred from solvent site-guided molecular docking, emphasizing the stereochemical complementarity of the coenzyme-binding site to licochalcone A. Sequence analysis across PTGR1 orthologs in vertebrates and exploration of 3D structures of human NADPH-binding proteins further underscore the potential of the coenzyme-binding site as a scaffold for developing PTGR1-specific inhibitors, positioning licochalcone A as a promising lead compound.

Słowa kluczowe:

Leukotriene B4 dehydrogenase, NADPH-dependent enzyme, Molecular dynamics simulation, Covalent inhibition, Specific target for cancer therapy

Afiliacje autorów:

Sara Abigail R.-other affiliation
Durán-Vargas A.-other affiliation
Jesús Antonio R.-other affiliation
Mendoza-Espinosa P.-other affiliation
Cofas Vargas L.F.-IPPT PAN
Armando C.-other affiliation
Julio Isael P.-other affiliation
García-Hernandez E.-other affiliation
70p.